"And that could push it into 2022. Previously we had talked about trying to have that data available before the end of this year, which could have prompted an authorization perhaps by the end of the year, at least in kids ages 2-4. I think that it's more likely that it slips into the first quarter of next year at the very least, but not too far into next year," said Gottlieb, who is also on Pfizer's board.
The rate of Covid-19 cases is dropping nationally but rising in these 5 states - KAKE
Read More
No comments:
Post a Comment